Using positron-emission tomography–computed tomography for predicting radiotherapy-induced tumor regression in carcinoma esophagus in an Indian population

Carcinoma esophagus is a common malignancy of the Indian subcontinent. The role of positron-emission tomography–computed tomography (PET-CT) in the assessment of response to radiotherapy has been widely studied and accepted. However, its precise use as a predictive tool for actual histopathological...

Full description

Saved in:
Bibliographic Details
Main Authors: Sankalp Singh, Niharika Bisht, Arti Sarin, A. V. S. Kumar, Samir Gupta, Amul Kapoor, Prabha Mishra
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-10-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_114_18
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849324821558591488
author Sankalp Singh
Niharika Bisht
Arti Sarin
A. V. S. Kumar
Samir Gupta
Amul Kapoor
Prabha Mishra
author_facet Sankalp Singh
Niharika Bisht
Arti Sarin
A. V. S. Kumar
Samir Gupta
Amul Kapoor
Prabha Mishra
author_sort Sankalp Singh
collection DOAJ
description Carcinoma esophagus is a common malignancy of the Indian subcontinent. The role of positron-emission tomography–computed tomography (PET-CT) in the assessment of response to radiotherapy has been widely studied and accepted. However, its precise use as a predictive tool for actual histopathological response to radiotherapy needs further evaluation, especially in an Indian population. The aim of this study was to identify a quantum of metabolic response on PET-CT that can also predict for a good pathological response. Forty-four patients of carcinoma esophagus treated with neoadjuvant chemoradiotherapy followed by surgery were included in the study. All patients underwent a PET-CT before starting treatment as well as at 4–6 weeks after completion of radiotherapy. The percentage change in pre and posttreatment maximum standardized uptake value (SUVmax) value (ΔSUV%) of the primary tumor was correlated against histopathological tumor regression grade (TRG) as per the Mandard's system. Seventy-five percent of the patients with a significant metabolic response, i.e., a ΔSUV% of 60% or more, also had a good pathological response to treatment. Thus, by considering a ΔSUV% of 60%, we could predict for a good pathological response (TRG of 1 or 2) to chemoradiotherapy in our patient set with a sensitivity of 95.45% and a specificity of 72.72%.
format Article
id doaj-art-7c948233fe0e48248b4feca550ceec4d
institution Kabale University
issn 1450-1147
1607-3312
language English
publishDate 2019-10-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series World Journal of Nuclear Medicine
spelling doaj-art-7c948233fe0e48248b4feca550ceec4d2025-08-20T03:48:36ZengThieme Medical and Scientific Publishers Pvt. Ltd.World Journal of Nuclear Medicine1450-11471607-33122019-10-01180436136510.4103/wjnm.WJNM_114_18Using positron-emission tomography–computed tomography for predicting radiotherapy-induced tumor regression in carcinoma esophagus in an Indian populationSankalp Singh0Niharika Bisht1Arti Sarin2A. V. S. Kumar3Samir Gupta4Amul Kapoor5Prabha Mishra6Department of Radiation Oncology, Command Hospital (CC), Lucknow, Uttar Pradesh, IndiaDepartment of Malignant Disease Treatment Centre, Command Hospital (SC), Pune, Maharashtra, IndiaDepartment of Malignant Disease Treatment Centre, Command Hospital (SC), Pune, Maharashtra, IndiaDepartment of Nuclear Medicine, Command Hospital (SC), Pune, Maharashtra, IndiaDepartment of Malignant Disease Treatment Centre, Command Hospital (SC), Pune, Maharashtra, IndiaDepartment of Malignant Disease Treatment Centre, Command Hospital (SC), Pune, Maharashtra, IndiaDepartment of Pathology, Command Hospital (SC), Pune, Maharashtra, IndiaCarcinoma esophagus is a common malignancy of the Indian subcontinent. The role of positron-emission tomography–computed tomography (PET-CT) in the assessment of response to radiotherapy has been widely studied and accepted. However, its precise use as a predictive tool for actual histopathological response to radiotherapy needs further evaluation, especially in an Indian population. The aim of this study was to identify a quantum of metabolic response on PET-CT that can also predict for a good pathological response. Forty-four patients of carcinoma esophagus treated with neoadjuvant chemoradiotherapy followed by surgery were included in the study. All patients underwent a PET-CT before starting treatment as well as at 4–6 weeks after completion of radiotherapy. The percentage change in pre and posttreatment maximum standardized uptake value (SUVmax) value (ΔSUV%) of the primary tumor was correlated against histopathological tumor regression grade (TRG) as per the Mandard's system. Seventy-five percent of the patients with a significant metabolic response, i.e., a ΔSUV% of 60% or more, also had a good pathological response to treatment. Thus, by considering a ΔSUV% of 60%, we could predict for a good pathological response (TRG of 1 or 2) to chemoradiotherapy in our patient set with a sensitivity of 95.45% and a specificity of 72.72%.http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_114_18carcinoma esophaguspositron-emission tomography–computed tomographyradiotherapy
spellingShingle Sankalp Singh
Niharika Bisht
Arti Sarin
A. V. S. Kumar
Samir Gupta
Amul Kapoor
Prabha Mishra
Using positron-emission tomography–computed tomography for predicting radiotherapy-induced tumor regression in carcinoma esophagus in an Indian population
World Journal of Nuclear Medicine
carcinoma esophagus
positron-emission tomography–computed tomography
radiotherapy
title Using positron-emission tomography–computed tomography for predicting radiotherapy-induced tumor regression in carcinoma esophagus in an Indian population
title_full Using positron-emission tomography–computed tomography for predicting radiotherapy-induced tumor regression in carcinoma esophagus in an Indian population
title_fullStr Using positron-emission tomography–computed tomography for predicting radiotherapy-induced tumor regression in carcinoma esophagus in an Indian population
title_full_unstemmed Using positron-emission tomography–computed tomography for predicting radiotherapy-induced tumor regression in carcinoma esophagus in an Indian population
title_short Using positron-emission tomography–computed tomography for predicting radiotherapy-induced tumor regression in carcinoma esophagus in an Indian population
title_sort using positron emission tomography computed tomography for predicting radiotherapy induced tumor regression in carcinoma esophagus in an indian population
topic carcinoma esophagus
positron-emission tomography–computed tomography
radiotherapy
url http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_114_18
work_keys_str_mv AT sankalpsingh usingpositronemissiontomographycomputedtomographyforpredictingradiotherapyinducedtumorregressionincarcinomaesophagusinanindianpopulation
AT niharikabisht usingpositronemissiontomographycomputedtomographyforpredictingradiotherapyinducedtumorregressionincarcinomaesophagusinanindianpopulation
AT artisarin usingpositronemissiontomographycomputedtomographyforpredictingradiotherapyinducedtumorregressionincarcinomaesophagusinanindianpopulation
AT avskumar usingpositronemissiontomographycomputedtomographyforpredictingradiotherapyinducedtumorregressionincarcinomaesophagusinanindianpopulation
AT samirgupta usingpositronemissiontomographycomputedtomographyforpredictingradiotherapyinducedtumorregressionincarcinomaesophagusinanindianpopulation
AT amulkapoor usingpositronemissiontomographycomputedtomographyforpredictingradiotherapyinducedtumorregressionincarcinomaesophagusinanindianpopulation
AT prabhamishra usingpositronemissiontomographycomputedtomographyforpredictingradiotherapyinducedtumorregressionincarcinomaesophagusinanindianpopulation